Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Endometrial Cancer Cells
54%
TP53 mutation
50%
Metadherin
50%
RNA Modification
50%
Inosine
50%
Mouse Oocyte
50%
Codon
50%
MRNA Decay
36%
Tumor Protein p53 (TP53)
33%
Maternal mRNA
32%
Cell-to-cell
31%
Ovarian Cancer
29%
MicroRNA
29%
Knockdown
27%
Mtdh
25%
Conventional Chemotherapy
25%
Taxanes
25%
Serous Ovarian Carcinoma
25%
Wobble Position
25%
Transcription Complex
25%
LBH589
25%
CCR4
25%
Gefitinib
25%
Epithelium
25%
Follicular Fluid
25%
Histone Deacetylase Inhibitor (HDACi)
25%
RNA-binding Protein
25%
Co-treatment
25%
Cell Death Induction
25%
MicroRNA Regulation
25%
Mouse Egg
25%
Survival Benefit
25%
Cytidine Deaminase
25%
Paclitaxel
25%
Mitotic Cell Death
25%
Death Receptor Ligand
25%
G2-M Checkpoint
25%
Codon Composition
25%
Human Oocyte
25%
Reproductive Aging
25%
Age-associated
25%
Protein Abundance
25%
Age-associated
25%
Chemoresistance
20%
BI2536
19%
Tumor
19%
Aged Oocyte
16%
Oocyte Maturation
15%
DNA Damage
13%
Epithelial Cells
13%
Medicine and Dentistry
Cancer Cell
72%
Uterine Cancer
63%
Drug Resistance
63%
Ovarian Cancer
50%
Cell Death
50%
Protein P53
42%
Krukenberg Tumor
29%
Cancer
25%
Epithelial Cell
25%
Cytidine Deaminase
25%
Death Receptor
25%
RNA Binding Protein
25%
Panobinostat
25%
Histone Deacetylase Inhibitor
25%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
25%
DNA Damage
21%
Tumor
20%
The Cancer Genome Atlas
16%
Progression Free Survival
16%
Tumor Suppressor Protein
16%
Ovarian Tumor
16%
Protein Expression
14%
Paclitaxel
14%
Gefitinib
14%
Diseases
13%
Tumor Progression
12%
Cell Cycle Checkpoint
11%
4 (8 Cyclopentyl 7 Ethyl 5,6,7,8 Tetrahydro 5 Methyl 6 Oxo 2 Pteridinylamino) 3 Methoxy N (1 Methyl 4 Piperidinyl)benzamide
10%
Cell Proliferation
10%
Polo Like Kinase 1
10%
Oncogene
8%
Biological Marker
8%
Tumor Suppressor Gene
8%
Drug Response
8%
Gain of Function Mutation
8%
Protein Function
8%
Ovarian Cancer Cell Line
8%
Adjuvant Chemotherapy
8%
Recurrence Free Survival
8%
Recurrent Disease
8%
Oncogenic activity
8%
Treatment Option
8%
Cell DNA
7%
Mutagenic Agent
7%
Endometrium Tumor
7%
Cell Cycle Arrest
6%
PDCD10
6%
Solid Malignant Neoplasm
6%
Prostate Tumor
6%
Cell Survival
6%
Biochemistry, Genetics and Molecular Biology
Messenger RNA
100%
Codon
76%
Inosine
50%
RNA Modification
50%
Cancer Cell
38%
Transcription
31%
MicroRNA
29%
Drug Resistance
27%
Histone Deacetylase
25%
Follicular Fluid
25%
CCR4
25%
Programmed Cell Death
25%
Cell Death
25%
Cytidine Deaminase
25%
RNA-binding Protein
25%
Tumor Necrosis Factor
21%
DNA Damage
13%
RNA Sequencing
10%
Cell Cycle Checkpoint
10%
Maturation
9%
Oocyte Maturation
9%
Metaphase
8%
RNA
8%
Proteomics
8%
Proteome
8%
Bioinformatics
8%
Coding Region
8%
Gene Expression
7%
Gene Translocation
6%
B Cell
6%
Blood Plasma
6%
Cell Proliferation
6%
mRNA Stability
6%
PDCD10
6%
Cell Cycle Arrest
6%
N-Terminus
6%
Protein Expression
6%
Tyrosine Kinase Inhibitor
6%
Carcinogenesis
6%
Nucleic Acid
6%
RNA-induced Silencing Complex
6%
Cofactor
6%
Cell Membrane
6%
Stress Granule
6%
Cell Survival
6%
Embryogenesis
5%
